US-based Real-time Elastography for the Detection of Fibrotic Gut Tissue in Patients with Stricturing Crohn Disease

Published Online:

US-based real-time elastography can be used to reliably detect fibrotic gut tissue in patients with Crohn disease.


To assess whether ultrasonography (US)-based real-time elastography (RTE) can be used to detect gut fibrosis.

Materials and Methods

In this institutional review board–approved, prospective, proof-of-concept study, unaffected and affected gut segments in 10 patients with Crohn disease (four women, six men; median age, 49 years) were examined pre-, intra-, and postoperatively with US, including RTE to assess strain. Disease activity was scored by using the Limberg index on the basis of (a) bowel wall thickness and (b) size and extent of Doppler signal. After surgical resection, strain of full gut wall segments was measured with direct tensiometry. Gut wall layers, fibrosis, and collagen content were quantified histologically. Aggregated data per patient, disease status, and available measurements were assessed with mixed-effects models.


Unaffected versus affected gut segments yielded higher RTE (mean ± standard deviation, 169.0 ± 27.9 vs 43.0 ± 25.9, respectively) and tensiometry (mean, 77.1 ± 21.4 vs 13.3 ± 11.2, respectively) values used to assess strain (both P < .001). There was good correlation between pre-, intra-, and postoperative RTE values of unaffected (intraclass correlation coefficient, 0.572) and affected (intraclass correlation coefficient, 0.830) segments. RTE was not associated with pre- or intraoperative Limberg scores (median, 1 vs 2; P = .255 and .382, respectively). Affected internal (median, 2011 vs 1363 μm; P = .011) and external (median, 929 vs 632 μm; P = .013) muscularis propria, serosa (median, 245 vs 64 μm; P = .019), and muscularis mucosae (median, 451 vs 80 μm; P = .031) were wider than unaffected segments. Width differences of internal muscularis propria and mucularis mucosae were associated with RTE-assessed strain (P = .044 and .012, respectively) and tensiometry-assessed strain (P = .006 and .014, respectively). Masson trichrome (median, 4 vs 0; P < .001) and elastica–van Gieson (median, 805 346 μm2 vs 410 649 μm2; P < .001) stains and western blotting (median, 2.01 vs 0.87; P = .009) demonstrated a higher collagen content in affected versus unaffected segments and were associated with RTE-assessed strain (both P < .001) and tensiometry-assessed strain (P < .001 and 0.025, respectively).


RTE can be used to detect fibrosis in human Crohn disease.

© RSNA, 2015

Online supplemental material is available for this article.


  • 1. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet 2012;380(9853):1590–1605. Crossref, MedlineGoogle Scholar
  • 2. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol 2010;105(2):289–297. Crossref, MedlineGoogle Scholar
  • 3. Khoury W, Strong SA, Fazio VW, Kiran RP. Factors associated with operative recurrence early after resection for Crohn’s disease. J Gastrointest Surg 2011;15(8):1354–1360. Crossref, MedlineGoogle Scholar
  • 4. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: current management. J Crohn’s Colitis 2010;4(1):28–62. [Published correction appears in J Crohns Colitis 2010;4(3):353. Dosage error in article text.] Crossref, MedlineGoogle Scholar
  • 5. Van Assche G, Vermeire S, Rutgeerts P. The potential for disease modification in Crohn’s disease. Nat Rev Gastroenterol Hepatol 2010;7(2):79–85. Crossref, MedlineGoogle Scholar
  • 6. D’Haens GR, Fedorak R, Lémann M, et al. Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn’s disease. Inflamm Bowel Dis 2009;15(10):1599–1604. Crossref, MedlineGoogle Scholar
  • 7. Pariente B, Cosnes J, Danese S, et al. Development of the Crohn’s disease digestive damage score, the Lémann score. Inflamm Bowel Dis 2011;17(6):1415–1422. Crossref, MedlineGoogle Scholar
  • 8. Ophir J, Céspedes I, Ponnekanti H, Yazdi Y, Li X. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging 1991;13(2):111–134. Crossref, MedlineGoogle Scholar
  • 9. Bharucha AE, Hubmayr RD, Ferber IJ, Zinsmeister AR. Viscoelastic properties of the human colon. Am J Physiol Gastrointest Liver Physiol 2001;281(2):G459–G466. Crossref, MedlineGoogle Scholar
  • 10. Egorov VI, Schastlivtsev IV, Prut EV, Baranov AO, Turusov RA. Mechanical properties of the human gastrointestinal tract. J Biomech 2002;35(10):1417–1425. Crossref, MedlineGoogle Scholar
  • 11. Stidham RW, Xu J, Johnson LA, et al. Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn’s disease. Gastroenterology 2011;141(3):819–826, e1. Crossref, MedlineGoogle Scholar
  • 12. Shiina T, Yamakawa M. Fast reconstruction of tissue elastic modulus image by ultrasound. Conf Proc IEEE Eng Med Biol Soc 2005;1:976–980. MedlineGoogle Scholar
  • 13. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(Suppl A):5A–36A. Crossref, MedlineGoogle Scholar
  • 14. Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet 1980;1(8167):514. Crossref, MedlineGoogle Scholar
  • 15. Limberg B. Diagnosis of chronic inflammatory bowel disease by ultrasonography [in German]. Z Gastroenterol 1999;37(6):495–508. MedlineGoogle Scholar
  • 16. Dou Y, Fan Y, Zhao J, Gregersen H. Longitudinal residual strain and stress-strain relationship in rat small intestine. Biomed Eng Online 2006;5:37. Crossref, MedlineGoogle Scholar
  • 17. Magro F, Langner C, Driessen A, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohn’s Colitis 2013;7(10):827–851. Crossref, MedlineGoogle Scholar
  • 18. Bataille F, Klebl F, Rümmele P, et al. Histopathological parameters as predictors for the course of Crohn’s disease. Virchows Arch 2003;443(4):501–507. Crossref, MedlineGoogle Scholar
  • 19. Girlich C, Jung EM, Huber E, et al. Comparison between preoperative quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and operative macroscopic findings and results of histopathological scoring in Crohn’s disease. Ultraschall Med 2011;32(2):154–159. Crossref, MedlineGoogle Scholar
  • 20. Theiss AL, Fuller CR, Simmons JG, Liu B, Sartor RB, Lund PK. Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation. Gastroenterology 2005;129(1):204–219. Crossref, MedlineGoogle Scholar
  • 21. Peterson TC, Peterson MR, Raoul JM. The effect of pentoxifylline and its metabolite-1 on inflammation and fibrosis in the TNBS model of colitis. Eur J Pharmacol 2011;662(1-3):47–54. Crossref, MedlineGoogle Scholar
  • 22. Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn’s disease complicated by strictures: a systematic review. Gut 2013;62(7):1072–1084. Crossref, MedlineGoogle Scholar
  • 23. Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem 2010;285(26):20202–20212. Crossref, MedlineGoogle Scholar
  • 24. Li C, Kuemmerle JF. Mechanisms that mediate the development of fibrosis in patients with Crohn’s disease. Inflamm Bowel Dis 2014;20(7):1250–1258. Crossref, MedlineGoogle Scholar
  • 25. Gelbmann CM, Mestermann S, Gross V, Köllinger M, Schölmerich J, Falk W. Strictures in Crohn’s disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut 1999;45(2):210–217. Crossref, MedlineGoogle Scholar
  • 26. Nylund K, Leh S, Immervoll H, et al. Crohn’s disease: comparison of in vitro ultrasonographic images and histology. Scand J Gastroenterol 2008;43(6):719–726. Crossref, MedlineGoogle Scholar
  • 27. Shelley-Fraser G, Borley NR, Warren BF, Shepherd NA. The connective tissue changes of Crohn’s disease. Histopathology 2012;60(7):1034–1044. Crossref, MedlineGoogle Scholar
  • 28. Stallmach A, Schuppan D, Riese HH, Matthes H, Riecken EO. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn’s disease. Gastroenterology 1992;102(6):1920–1929. Crossref, MedlineGoogle Scholar
  • 29. Kim K, Johnson LA, Jia C, et al. Noninvasive ultrasound elasticity imaging (UEI) of Crohn’s disease: animal model. Ultrasound Med Biol 2008;34(6):902–912. Crossref, MedlineGoogle Scholar
  • 30. Dillman JR, Stidham RW, Higgins PD, Moons DS, Johnson LA, Rubin JM. US elastography-derived shear wave velocity helps distinguish acutely inflamed from fibrotic bowel in a Crohn disease animal model. Radiology 2013;267(3):757–766. LinkGoogle Scholar
  • 31. Stidham RW, Xu J, Johnson LA, et al. Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn’s disease. Gastroenterology 2011;141(3):819–826, e1. Crossref, MedlineGoogle Scholar
  • 32. Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohn’s Colitis 2013;7(7):556–585. Crossref, MedlineGoogle Scholar
  • 33. Quencer KB, Nimkin K, Mino-Kenudson M, Gee MS. Detecting active inflammation and fibrosis in pediatric Crohn’s disease: prospective evaluation of MR-E and CT-E. Abdom Imaging 2013;38(4):705–713. Crossref, MedlineGoogle Scholar
  • 34. Ha CY, Kumar N, Raptis CA, Narra VR, Ciorba MA. Magnetic resonance enterography: safe and effective imaging for stricturing Crohn’s disease. Dig Dis Sci 2011;56(10):2906–2913. Crossref, MedlineGoogle Scholar
  • 35. Ripollés T, Rausell N, Paredes JM, Grau E, Martínez MJ, Vizuete J. Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn’s disease: a comparison with surgical histopathology analysis. J Crohn’s Colitis 2013;7(2):120–128. Crossref, MedlineGoogle Scholar
  • 36. Quaia E, De Paoli L, Stocca T, Cabibbo B, Casagrande F, Cova MA. The value of small bowel wall contrast enhancement after sulfur hexafluoride-filled microbubble injection to differentiate inflammatory from fibrotic strictures in patients with Crohn’s disease. Ultrasound Med Biol 2012;38(8):1324–1332. Crossref, MedlineGoogle Scholar
  • 37. Adler J, Punglia DR, Dillman JR, et al. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn’s disease. Inflamm Bowel Dis 2012;18(5):849–856. Crossref, MedlineGoogle Scholar
  • 38. Gee MS, Nimkin K, Hsu M, et al. Prospective evaluation of MR enterography as the primary imaging modality for pediatric Crohn disease assessment. AJR Am J Roentgenol 2011;197(1):224–231. Crossref, MedlineGoogle Scholar
  • 39. Zappa M, Stefanescu C, Cazals-Hatem D, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn’s disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 2011;17(4):984–993. Crossref, MedlineGoogle Scholar

Article History

Received August 28, 2014; revision requested October 31; revision received November 11; accepted November 19; final version accepted December 16.
Published online: Feb 06 2015
Published in print: June 2015